Localization of association signal from risk and protective variants in sequencing studies

Abra Brisbin, Gregory D. Jenkins, Katarzyna A. Ellsworth, Liewei M Wang, Brooke L. Fridley

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aggregating information across multiple variants in a gene or region can improve power for rare variant association testing. Power is maximized when the aggregation region contains many causal variants and few neutral variants. In this paper, we present a method for the localization of the association signal in a region using a sliding-window based approach to rare variant association testing in a region. We first introduce a novel method for analysis of rare variants, the Difference in Minor Allele Frequency test (DMAF), which allows combined analysis of common and rare variants, and makes no assumptions about the direction of effects. In whole-region analyses of simulated data with risk and protective variants, DMAF and other methods which pool data across individuals were found to outperform methods which pool data across variants. We then implement a sliding-window version of DMAF, using a step-down permutation approach to control type I error with the testing of multiple windows. In simulations, the sliding-window DMAF improved power to detect a causal sub-region, compared to applying DMAF to the whole region. Sliding-window DMAF was also effective in localizing the causal sub-region. We also applied the DMAF sliding-window approach to test for an association between response to the drug gemcitabine and variants in the gene FKBP5 sequenced in 91 lymphoblastoid cell lines derived from white non-Hispanic individuals. The application of the sliding-window test procedure detected an association in a sub-region spanning an exon and two introns, when rare and common variants were analyzed together.

Original languageEnglish (US)
Article numberArticle 173
JournalFrontiers in Genetics
Volume3
Issue numberSEP
DOIs
StatePublished - 2012

Fingerprint

Gene Frequency
gemcitabine
Introns
Genes
Exons
Cell Line
Pharmaceutical Preparations

Keywords

  • Multiple testing
  • Rare variants
  • Region-based analysis

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Genetics(clinical)

Cite this

Localization of association signal from risk and protective variants in sequencing studies. / Brisbin, Abra; Jenkins, Gregory D.; Ellsworth, Katarzyna A.; Wang, Liewei M; Fridley, Brooke L.

In: Frontiers in Genetics, Vol. 3, No. SEP, Article 173, 2012.

Research output: Contribution to journalArticle

Brisbin, Abra ; Jenkins, Gregory D. ; Ellsworth, Katarzyna A. ; Wang, Liewei M ; Fridley, Brooke L. / Localization of association signal from risk and protective variants in sequencing studies. In: Frontiers in Genetics. 2012 ; Vol. 3, No. SEP.
@article{501ee6f2a5834fe3bc768968e61d4d85,
title = "Localization of association signal from risk and protective variants in sequencing studies",
abstract = "Aggregating information across multiple variants in a gene or region can improve power for rare variant association testing. Power is maximized when the aggregation region contains many causal variants and few neutral variants. In this paper, we present a method for the localization of the association signal in a region using a sliding-window based approach to rare variant association testing in a region. We first introduce a novel method for analysis of rare variants, the Difference in Minor Allele Frequency test (DMAF), which allows combined analysis of common and rare variants, and makes no assumptions about the direction of effects. In whole-region analyses of simulated data with risk and protective variants, DMAF and other methods which pool data across individuals were found to outperform methods which pool data across variants. We then implement a sliding-window version of DMAF, using a step-down permutation approach to control type I error with the testing of multiple windows. In simulations, the sliding-window DMAF improved power to detect a causal sub-region, compared to applying DMAF to the whole region. Sliding-window DMAF was also effective in localizing the causal sub-region. We also applied the DMAF sliding-window approach to test for an association between response to the drug gemcitabine and variants in the gene FKBP5 sequenced in 91 lymphoblastoid cell lines derived from white non-Hispanic individuals. The application of the sliding-window test procedure detected an association in a sub-region spanning an exon and two introns, when rare and common variants were analyzed together.",
keywords = "Multiple testing, Rare variants, Region-based analysis",
author = "Abra Brisbin and Jenkins, {Gregory D.} and Ellsworth, {Katarzyna A.} and Wang, {Liewei M} and Fridley, {Brooke L.}",
year = "2012",
doi = "10.3389/fgene.2012.00173",
language = "English (US)",
volume = "3",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Localization of association signal from risk and protective variants in sequencing studies

AU - Brisbin, Abra

AU - Jenkins, Gregory D.

AU - Ellsworth, Katarzyna A.

AU - Wang, Liewei M

AU - Fridley, Brooke L.

PY - 2012

Y1 - 2012

N2 - Aggregating information across multiple variants in a gene or region can improve power for rare variant association testing. Power is maximized when the aggregation region contains many causal variants and few neutral variants. In this paper, we present a method for the localization of the association signal in a region using a sliding-window based approach to rare variant association testing in a region. We first introduce a novel method for analysis of rare variants, the Difference in Minor Allele Frequency test (DMAF), which allows combined analysis of common and rare variants, and makes no assumptions about the direction of effects. In whole-region analyses of simulated data with risk and protective variants, DMAF and other methods which pool data across individuals were found to outperform methods which pool data across variants. We then implement a sliding-window version of DMAF, using a step-down permutation approach to control type I error with the testing of multiple windows. In simulations, the sliding-window DMAF improved power to detect a causal sub-region, compared to applying DMAF to the whole region. Sliding-window DMAF was also effective in localizing the causal sub-region. We also applied the DMAF sliding-window approach to test for an association between response to the drug gemcitabine and variants in the gene FKBP5 sequenced in 91 lymphoblastoid cell lines derived from white non-Hispanic individuals. The application of the sliding-window test procedure detected an association in a sub-region spanning an exon and two introns, when rare and common variants were analyzed together.

AB - Aggregating information across multiple variants in a gene or region can improve power for rare variant association testing. Power is maximized when the aggregation region contains many causal variants and few neutral variants. In this paper, we present a method for the localization of the association signal in a region using a sliding-window based approach to rare variant association testing in a region. We first introduce a novel method for analysis of rare variants, the Difference in Minor Allele Frequency test (DMAF), which allows combined analysis of common and rare variants, and makes no assumptions about the direction of effects. In whole-region analyses of simulated data with risk and protective variants, DMAF and other methods which pool data across individuals were found to outperform methods which pool data across variants. We then implement a sliding-window version of DMAF, using a step-down permutation approach to control type I error with the testing of multiple windows. In simulations, the sliding-window DMAF improved power to detect a causal sub-region, compared to applying DMAF to the whole region. Sliding-window DMAF was also effective in localizing the causal sub-region. We also applied the DMAF sliding-window approach to test for an association between response to the drug gemcitabine and variants in the gene FKBP5 sequenced in 91 lymphoblastoid cell lines derived from white non-Hispanic individuals. The application of the sliding-window test procedure detected an association in a sub-region spanning an exon and two introns, when rare and common variants were analyzed together.

KW - Multiple testing

KW - Rare variants

KW - Region-based analysis

UR - http://www.scopus.com/inward/record.url?scp=84876160110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876160110&partnerID=8YFLogxK

U2 - 10.3389/fgene.2012.00173

DO - 10.3389/fgene.2012.00173

M3 - Article

C2 - 22973297

AN - SCOPUS:84876160110

VL - 3

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - SEP

M1 - Article 173

ER -